Maggie Flanagan LeFlore
Keine laufenden Positionen mehr
Karriereverlauf von Maggie Flanagan LeFlore
Ehemalige bekannte Positionen von Maggie Flanagan LeFlore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Private Equity Investor | 01.06.2007 | 30.03.2010 |
| ASTRIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 23.04.2010 | - |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 27.11.2009 | - |
Ausbildung von Maggie Flanagan LeFlore
| University of Kansas | Undergraduate Degree |
| Indiana University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
NKT Therapeutics, Inc.
NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Maggie Flanagan LeFlore
- Erfahrung
